Content Options:

Add to favourites

View Options:

More Resources:

External link Handbook Publications

DTR 1.1 Application and purpose

DTR 1.1.1 R RP

1The disclosure rules apply as follows:

  1. (1)

    DTR 1 and DTR 2 apply to an issuer whose financial instruments are admitted to trading on a regulated market in the United Kingdom or for which a request for admission to trading on a regulated market in the United Kingdom has been made;

  2. (2)

    DTR 3 applies to an issuer that is incorporated in the United Kingdom:

    1. (a)

      whose financial instruments are admitted to trading on a regulated market; or

    2. (b)

      for whose financial instruments a request for admission to trading on a regulated market in the United Kingdom has been made;

  3. (3)

    the following apply to person discharging managerial responsibility, including directors, and connected persons:

    1. (a)

      DTR 1.1 and DTR 1.2;

    2. (b)

      DTR 1.3.1 R - DTR 1.3.2 G and DTR 1.3.8 R;

    3. (c)

      DTR 1.4;

    4. (d)

      DTR 1.5.3 G; and

    5. (e)

      DTR 3; and

  4. (4)

    DTR 3 applies to a non-EEA stateissuer which is required to file, with the FSA, annual information in relation to shares in accordance with Article 10 of the Prospectus Directive.

Purpose

DTR 1.1.2 G RP

The purpose of the disclosure rules is to implement:

  1. (1)

    Article 6 of the Market Abuse Directive;

  2. (2)

    Articles 2 and 3 of Commission Directive 2003/124/EC; and

  3. (3)

    Articles 5 and 6 of Commission Directive 2004/72/EC.

FSA

DTR 1.1.3 G RP

In relation to the disclosure rules, the FSA is exercising its functions as the competent authority under Part VI of the Act (see section 72(1) of the Act).

Other relevant parts of Handbook

Note: Other parts of the Handbook that may also be relevant to persons to whom

the disclosure rules apply include DEC (the Decision making manual), Chapter 9 of SUP (the Supervision manual) and Chapter 21 of ENF (the Enforcement manual).

Note: A list of regulated markets can be found on the FSA website at the following address: www.fsa.gov.uk/register/exchanges.do

DTR 1.2 Modifying rules and consulting the FSA

Modifying or dispensing with rules

DTR 1.2.1 R

  1. (1)

    The FSA may dispense with, or modify, the disclosure rules in such cases and by reference to such circumstances as it considers appropriate (subject to the terms of directives and the Act).

  2. (2)

    A dispensation or modification may be either unconditional or subject to specified conditions.

  3. (3)

    If an issuer, person discharging managerial responsibilities or a connected person has applied for, or been granted, a dispensation or modification, it must notify the FSA immediately it becomes aware of any matter which is material to the relevance or appropriateness of the dispensation or modification.

  4. (4)

    The FSA may revoke or modify a dispensation or modification.

DTR 1.2.2 R

  1. (1)

    An application to the FSA to dispense with or modify, a disclosure rule must be in writing.

  2. (2)

    The application must:

    1. (a)

      contain a clear explanation of why the dispensation or modification is requested;

    2. (b)

      include details of any special requirements, for example, the date by which the dispensation or modification is required;

    3. (c)

      contain all relevant information that should reasonably be brought to the FSA's attention;

    4. (d)

      contain any statement or information that is required by the disclosure rule to be included for a specific type of dispensation or modification; and

    5. (e)

      include copies of all documents relevant to the application.

DTR 1.2.3 G

An application to dispense with or modify a disclosure rule should ordinarily be made at least five business days before the proposed dispensation or modification is to take effect.

Early consultation with FSA

DTR 1.2.4 G RP

An issuer, person discharging managerial responsibilities or connected person should consult with the FSA at the earliest possible stage if they:

  1. (1)

    are in doubt about how the disclosure rules apply in a particular situation; or

  2. (2)

    consider that it may be necessary for the FSA to dispense with or modify a disclosure rule.

    Address for correspondence

    Note: The FSA's address for correspondence in relation to the disclosure rules is:

    Company Monitoring Team

    Markets Division

    The Financial Services Authority

    25 The North Colonnade

    Canary Wharf

    London E14 5HS

    Fax: 020 7066 8368

DTR 1.3 Information gathering and publication

Information gathering

DTR 1.3.1 R

An issuer, person discharging managerial responsibilities or connected person must provide to the FSA as soon as possible following a request:

  1. (1)

    any information that the FSA considers appropriate to protect investors or ensure the smooth operation of the market; and

  2. (2)

    any other information or explanation that the FSA may require to verify whether the disclosure rules are being and have been complied with.

DTR 1.3.2 G RP

In gathering information under DTR 1.3.1 R, the FSA may contact the issuer, person discharging managerial responsibilities, connected person or their adviser directly. Telephone calls to and from the FSA may be recorded for regulatory purposes. The FSA may also require the issuer, person discharging managerial responsibilities, connected person or their advisers to provide information in writing.

FSA may require the publication of information

DTR 1.3.3 R

  1. (1)

    The FSA may, at any time, require an issuer to publish such information in such form and within such time limits as it considers appropriate to protect investors or to ensure the smooth operation of the market.

  2. (2)

    If an issuer fails to comply with a requirement under paragraph (1) the FSA may itself publish the information (after giving the issuer an opportunity to make representations as to why it should not be published).

Misleading information not to be published

DTR 1.3.4 R

An issuer must take all reasonable care to ensure that any information it notifies to a RIS is not misleading, false or deceptive and does not omit anything likely to affect the import of the information.

DTR 1.3.5 R

An issuer must not combine, in a manner likely to be misleading, a RIS announcement with the marketing of its activities. [Note: Article 2(1) 2003/124/EC]

Notification when a RIS is not open for business

DTR 1.3.6 R RP

If an issuer is required to notify information to a RIS at a time when a RIS is not open for business, it must distribute the information as soon as possible to:

  1. (1)

    not less than two national newspapers in the United Kingdom;

  2. (2)

    two newswire services operating in the United Kingdom; and

  3. (3)

    a RIS for release as soon as it opens.

DTR 1.3.7 G RP

The fact that a RIS is not open for business is not, in itself, sufficient grounds for delaying the disclosure or distribution of inside information.

English language

DTR 1.3.8 R

A notification to a RIS that is required under the disclosure rules must be in English.

DTR 1.4 Suspension of trading

DTR 1.4.1 R

The FSA may require the suspension of trading of a financial instrument with effect from such time as it may determine if there are reasonable grounds to suspect non-compliance with the disclosure rules.

DTR 1.4.2 R RP

If trading of an issuer's financial instruments is suspended, the issuer, any persons discharging managerial responsibilities and any connected person must continue to comply with all applicable disclosure rules.

DTR 1.4.3 R

If the FSA has required the suspension of trading of any financial instruments, it may impose such conditions on the procedure for lifting the suspension as it considers appropriate.

DTR 1.4.4 G RP

Examples of when the FSA may require the suspension of trading of a financial instrument include:

  1. (1)

    if an issuer fails to make a RIS announcement as required by the disclosure rules within the applicable time-limits which the FSA considers could affect the interests of investors or affect the smooth operation of the market; or

  2. (2)

    if there is or there may be a leak of inside information and the issuer is unwilling or unable to issue an appropriate RIS announcement within a reasonable period of time.

DTR 1.4.5 G RP

The decision-making procedures to be followed by the FSA when it:

  1. (1)

    requires the suspension of trading of a financial instrument; or

  2. (2)

    refuses an application by an issuer to lift a suspension made under section 96C;

are set out in DEC.

DTR 1.5 Fees, market abuse safe harbours and sanctions

Fees

DTR 1.5.1 G RP

An issuer must pay the fees set out in DTR 1 Annex 2 R to the FSA when they are due.

Market abuse safe harbours

DTR 1.5.2 R

Pursuant to section 118A(5) of the Act, behaviour conforming with the disclosure rules specified below does not amount to market abuse under section 118(1) of the Act:

  1. (1)

    DTR 1.3.4 R (Misleading information not to be published);

  2. (2)

    DTR 1.3.6 R (Notification when a RIS is not open for business);

  3. (3)

    DTR 2.2.1 R (Requirement to disclose inside information); and

  4. (4)

    DTR 2.5.1 R (Delaying disclosure).

Sanctions

DTR 1.5.3 G RP

  1. (1)

    If the FSA considers that an issuer, a person discharging managerial responsibilities or a connected person has breached any of the disclosure rules it may, subject to the provisions of the Act, impose on that person a financial penalty or publish a statement censuring that person.

  2. (2)

    If the FSA considers that a former director was knowingly concerned in a breach by an issuer it may, subject to the provisions of the Act, impose on that person a financial penalty.

DTR 1 Annex 2 1Annex 2R Fees payable in relation to the period 1 April 2005 to 31 March 2006

This annex belongs to DTR 1.5.1R
R

    Annual fees for the period 1 April 2005 to 31 March 2006

    All non-listed issuers of shares, depositary receipts and securitised derivatives. Annual fees for listed issuers in respect of Disclosure Rules obligations are incorporated in the annual fee for listed issuers under the Listing Rules.

    A non-listed issuer which becomes subject to the disclosure rules during the course of the financial year must pay a proportion of the annual fee which is calculated in accordance with the following Table 3.

    (1) For all non-listed issuers of securitised derivatives, depositary receipts and global depositary receipts the fees payable are set out in Table 1.

    (2) For all other non-listed issuers fees to be determined according to market capitalisation as set out in Table 2. The fee is calculated as follows:

    (a)

    the relevant minimum fee; plus

    (b)

    the cumulative total of the sums payable for each of the bands calculated by multiplying each relevant tranche of the firm's market capitalisation by the rate indicated for that tranche.

    Fees from other fee schedules contained in other sections of the sourcebook may be applicable to a single submission.

  1. Table 1

Annual fees for non-listed issuers of securitised derivatives, depositary receipts and global depositary receipts

    Issuer

    Fee amount

    Issuers of securitised derivatives

    2,400

    Issuers of depositary receipts and global depositary receipts

    2,880

  1. Table 2

    2. Fee payable

    Minimum fee ()

    2,400

    million of Market Capitalisation

    Fee (/m or part m of Market Capitalisation)

    0-100

    0

    >100 - 250

    9.448

    >250 - 1,000

    3.776

    >1,000 - 5,000

    1.256

    >5,000 - 25,000

    0.0236

    >25,000

    0.00632

  2. Table 3

    3. Quarter in which the non-listed issuer becomes subject to the Disclosure Rules

    Proportion payable

    1 July to 30 September inclusive

    75%

    1 October to 31 December inclusive

    50%

    1 January to 31 March inclusive

    25%